Latest news from EU institutions and bodies

The registration for the 11th Joint Consumer Protection Day organised by the three European Supervisory Authorities (EBA, EIOPA and ESMA – ESAs) on 3 October 2024 in Budapest, Hungary is now open. Interested stakeholders can register until 2 September 2024.

European Commission Speech Lisbon, 03 Jul 2024 This is great day. A big day. A big day for Europe. And a big day for all of you. In January 2022 I proposed a new and stronger mandate for you.   And today, tw...

The representatives of member states’ governments appointed three judges and an advocate-general to the Court of Justice as part of its 2024 partial renewal.

Marking a historic moment, one year ago today, Eurojust launched the International Centre for the Prosecution of the Crime of Aggression (ICPA) - a unique judicial coordination platform dedicated to supporting national investigations into the crime of aggression related to the war in Ukraine.Since its launch in July 2023, the ICPA has made significant progress in building a common investigative and prosecutorial strategy for cases on the crime of aggression. ICPA participants have selected relevant evidence to focus on, and have coordinated and strengthened ongoing investigative efforts at national level.

EIOPA publishes monthly technical information for Solvency II Relevant Risk-Free Interest Rate Term Structures – end-June 2024

EIOPA publishes biannual shifted risk-free rates for duration calculation in financial stability reporting – end-June 2024

Monthly update of the symmetric adjustment of the equity capital charge for Solvency II – end-June 2024

European Commission Press release Brussels, 03 Jul 2024 Canada is joining the growing group of non-EU countries who have associated to the EU's research and innovation programme, Horizon Europe, and will work jointly on large-scale projects tackling our biggest challenges.

The European Investment Bank (EIB) is providing venture debt financing to Belgian medical-technology company Nyxoah €37.5 million to develop treatments against obstructive sleep apnea.  This transaction aligns with the EIB’s priority objective to boost research and technological innovation, in line with the implementation of EU policies.